S&P 500   3,739.54 (-2.86%)
DOW   30,276.42 (-2.14%)
QQQ   319.71 (-2.70%)
AAPL   141.82 (-0.94%)
MSFT   232.06 (-0.12%)
FB   271.77 (-3.64%)
GOOGL   1,801.47 (-5.58%)
AMZN   3,240.23 (-2.58%)
TSLA   868.25 (-1.68%)
NVDA   515.24 (-4.13%)
BABA   261.51 (-1.66%)
CGC   37.75 (+6.28%)
GE   10.87 (-3.72%)
MU   74.94 (-5.75%)
AMD   88.96 (-6.07%)
NIO   56.97 (-5.54%)
T   29.22 (-1.78%)
F   10.80 (-3.49%)
ACB   11.34 (+6.28%)
BA   193.75 (-4.11%)
DIS   162.98 (-3.88%)
NFLX   531.75 (-5.37%)
GILD   65.55 (-1.72%)
S&P 500   3,739.54 (-2.86%)
DOW   30,276.42 (-2.14%)
QQQ   319.71 (-2.70%)
AAPL   141.82 (-0.94%)
MSFT   232.06 (-0.12%)
FB   271.77 (-3.64%)
GOOGL   1,801.47 (-5.58%)
AMZN   3,240.23 (-2.58%)
TSLA   868.25 (-1.68%)
NVDA   515.24 (-4.13%)
BABA   261.51 (-1.66%)
CGC   37.75 (+6.28%)
GE   10.87 (-3.72%)
MU   74.94 (-5.75%)
AMD   88.96 (-6.07%)
NIO   56.97 (-5.54%)
T   29.22 (-1.78%)
F   10.80 (-3.49%)
ACB   11.34 (+6.28%)
BA   193.75 (-4.11%)
DIS   162.98 (-3.88%)
NFLX   531.75 (-5.37%)
GILD   65.55 (-1.72%)
S&P 500   3,739.54 (-2.86%)
DOW   30,276.42 (-2.14%)
QQQ   319.71 (-2.70%)
AAPL   141.82 (-0.94%)
MSFT   232.06 (-0.12%)
FB   271.77 (-3.64%)
GOOGL   1,801.47 (-5.58%)
AMZN   3,240.23 (-2.58%)
TSLA   868.25 (-1.68%)
NVDA   515.24 (-4.13%)
BABA   261.51 (-1.66%)
CGC   37.75 (+6.28%)
GE   10.87 (-3.72%)
MU   74.94 (-5.75%)
AMD   88.96 (-6.07%)
NIO   56.97 (-5.54%)
T   29.22 (-1.78%)
F   10.80 (-3.49%)
ACB   11.34 (+6.28%)
BA   193.75 (-4.11%)
DIS   162.98 (-3.88%)
NFLX   531.75 (-5.37%)
GILD   65.55 (-1.72%)
S&P 500   3,739.54 (-2.86%)
DOW   30,276.42 (-2.14%)
QQQ   319.71 (-2.70%)
AAPL   141.82 (-0.94%)
MSFT   232.06 (-0.12%)
FB   271.77 (-3.64%)
GOOGL   1,801.47 (-5.58%)
AMZN   3,240.23 (-2.58%)
TSLA   868.25 (-1.68%)
NVDA   515.24 (-4.13%)
BABA   261.51 (-1.66%)
CGC   37.75 (+6.28%)
GE   10.87 (-3.72%)
MU   74.94 (-5.75%)
AMD   88.96 (-6.07%)
NIO   56.97 (-5.54%)
T   29.22 (-1.78%)
F   10.80 (-3.49%)
ACB   11.34 (+6.28%)
BA   193.75 (-4.11%)
DIS   162.98 (-3.88%)
NFLX   531.75 (-5.37%)
GILD   65.55 (-1.72%)
Log in
NASDAQ:NBIX

Neurocrine Biosciences SEC Filings & 10K Form

$111.63
-4.50 (-3.87 %)
(As of 01/27/2021 03:15 PM ET)
Add
Compare
Today's Range
$110.89
Now: $111.63
$117.00
50-Day Range
$90.21
MA: $102.18
$119.40
52-Week Range
$72.14
Now: $111.63
$136.26
Volume20,454 shs
Average Volume1.02 million shs
Market Capitalization$10.43 billion
P/E Ratio120.03
Dividend YieldN/A
Beta1.01

SEC Filings

Neurocrine Biosciences (NASDAQ:NBIX) SEC Filings

DateFilerForm TypeView
01/12/2021
3:17 PM
Neurocrine Biosciences (Issuer)
ROBERTS EIRY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/12/2021
3:16 PM
GORMAN KEVIN CHARLES (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2021
6:32 AM
Neurocrine Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/07/2020
6:23 PM
Neurocrine Biosciences (Issuer)
SHERWIN STEPHEN A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/02/2020
3:12 PM
ABERNETHY MATT (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/24/2020
7:02 AM
Neurocrine Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/19/2020
7:07 AM
Neurocrine Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/16/2020
5:27 PM
BENEVICH ERIC (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/16/2020
5:23 PM
Neurocrine Biosciences (Issuer)
ROBERTS EIRY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/16/2020
5:21 PM
Lloyd-Smith Malcolm (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/16/2020
5:20 PM
Lippoldt Darin (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/16/2020
5:19 PM
Grigoriadis Dimitri E. (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/16/2020
5:16 PM
GORMAN KEVIN CHARLES (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/16/2020
5:11 PM
Gano Kyle (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/16/2020
5:10 PM
Cooke Julie (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/16/2020
5:08 PM
Bozigian Haig P. (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/16/2020
5:02 PM
ABERNETHY MATT (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/09/2020
3:04 PM
Neurocrine Biosciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/09/2020
3:02 PM
Neurocrine Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/04/2020
5:09 PM
BENEVICH ERIC (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/06/2020
3:05 PM
Cooke Julie (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2020
6:51 PM
Neurocrine Biosciences (Issuer)
ROBERTS EIRY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2020
6:47 PM
Lloyd-Smith Malcolm (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2020
6:40 PM
Lippoldt Darin (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2020
6:36 PM
Grigoriadis Dimitri E. (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2020
6:29 PM
GORMAN KEVIN CHARLES (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2020
6:24 PM
Gano Kyle (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2020
6:21 PM
Cooke Julie (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2020
6:14 PM
Bozigian Haig P. (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2020
5:35 PM
BENEVICH ERIC (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2020
5:22 PM
ABERNETHY MATT (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/03/2020
3:45 PM
Neurocrine Biosciences (Filer)
Form S-8 POS
08/03/2020
3:40 PM
Neurocrine Biosciences (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
08/03/2020
3:14 PM
Neurocrine Biosciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/28/2020
3:10 PM
Neurocrine Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/10/2020
3:26 PM
Lippoldt Darin (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2020
3:19 PM
Neurocrine Biosciences (Issuer)
ROBERTS EIRY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2020
3:15 PM
Lippoldt Darin (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2020
6:10 AM
Neurocrine Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/15/2020
4:31 PM
Grigoriadis Dimitri E. (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2020
6:00 PM
Neurocrine Biosciences (Issuer)
SHERWIN STEPHEN A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2020
5:59 PM
Neurocrine Biosciences (Issuer)
POPS RICHARD F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2020
5:57 PM
Neurocrine Biosciences (Issuer)
Norwalk Leslie V (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2020
5:55 PM
MORROW GEORGE J (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2020
5:52 PM
LYONS GARY A (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2020
5:42 PM
Neurocrine Biosciences (Issuer)
RASTETTER WILLIAM H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2020
3:09 PM
Neurocrine Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/20/2020
6:15 PM
Lippoldt Darin (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2020
5:59 PM
Grigoriadis Dimitri E. (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2020
7:09 PM
Bozigian Haig P. (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/11/2020
7:17 PM
ABERNETHY MATT (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/11/2020
7:06 PM
Grigoriadis Dimitri E. (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/30/2020
3:27 PM
Neurocrine Biosciences (Issuer)
SHERWIN STEPHEN A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/28/2020
7:46 PM
Neurocrine Biosciences (Issuer)
ROBERTS EIRY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/28/2020
7:44 PM
Lloyd-Smith Malcolm (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/28/2020
7:43 PM
Lippoldt Darin (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/28/2020
7:42 PM
Grigoriadis Dimitri E. (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/28/2020
7:41 PM
GORMAN KEVIN CHARLES (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/28/2020
7:40 PM
Gano Kyle (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/28/2020
7:38 PM
Cooke Julie (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/28/2020
7:35 PM
Bozigian Haig P. (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/28/2020
7:33 PM
BENEVICH ERIC (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/28/2020
7:32 PM
ABERNETHY MATT (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/17/2020
8:48 PM
BENEVICH ERIC (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/09/2020
3:36 PM
Neurocrine Biosciences (Filer)
Form DEFA14A
04/09/2020
3:30 PM
Neurocrine Biosciences (Filer)
Form DEF 14A
04/09/2020
3:11 PM
Neurocrine Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/12/2020
7:02 AM
Neurocrine Biosciences (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
02/11/2020
6:23 PM
Neurocrine Biosciences (Issuer)
ROBERTS EIRY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/11/2020
6:21 PM
Lloyd-Smith Malcolm (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/11/2020
6:17 PM
Lippoldt Darin (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/11/2020
6:16 PM
Grigoriadis Dimitri E. (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/11/2020
6:14 PM
GORMAN KEVIN CHARLES (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/11/2020
6:13 PM
Gano Kyle (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/11/2020
6:10 PM
Cooke Julie (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/11/2020
6:09 PM
Bozigian Haig P. (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/11/2020
6:08 PM
BENEVICH ERIC (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/11/2020
6:06 PM
ABERNETHY MATT (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2020
6:32 AM
BlackRock Inc. (Filed by)
Neurocrine Biosciences (Subject)
Form SC 13G/A
02/07/2020
5:54 PM
Gano Kyle (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/07/2020
5:50 PM
Grigoriadis Dimitri E. (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/07/2020
5:49 PM
Neurocrine Biosciences (Issuer)
ROBERTS EIRY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/07/2020
5:47 PM
Lloyd-Smith Malcolm (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/07/2020
5:46 PM
Lippoldt Darin (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/07/2020
5:44 PM
GORMAN KEVIN CHARLES (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/07/2020
5:40 PM
ABERNETHY MATT (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/07/2020
5:38 PM
Cooke Julie (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/07/2020
5:37 PM
Bozigian Haig P. (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/07/2020
5:35 PM
BENEVICH ERIC (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2020
6:16 AM
Neurocrine Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/10/2020
3:10 PM
Neurocrine Biosciences (Issuer)
ROBERTS EIRY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2019
3:14 PM
Neurocrine Biosciences (Filed by)
Xenon Pharmaceuticals Inc. (Subject)
Form SC 13D
12/10/2019
8:43 AM
FMR LLC (Filed by)
Neurocrine Biosciences (Subject)
Form SC 13G/A
12/04/2019
5:06 PM
ABERNETHY MATT (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/19/2019
4:37 PM
Grigoriadis Dimitri E. (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/13/2019
3:41 PM
LYONS GARY A (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/13/2019
3:36 PM
Lippoldt Darin (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/04/2019
3:10 PM
Neurocrine Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/16/2019
3:20 PM
Lloyd-Smith Malcolm (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/04/2019
5:15 PM
Cooke Julie (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
This page was last updated on 1/27/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.